Ahmed Wasfy currently serves as the Subchapter Lead for Marketing Excellence in Molecular & Pathology at Roche Middle East, where he plays a pivotal role in driving strategic marketing initiatives within the diagnostics sector. With over eight years of experience in the industry, Ahmed has...
Ahmed Wasfy currently serves as the Subchapter Lead for Marketing Excellence in Molecular & Pathology at Roche Middle East, where he plays a pivotal role in driving strategic marketing initiatives within the diagnostics sector. With over eight years of experience in the industry, Ahmed has developed a robust expertise in product marketing and management, particularly in the molecular lab segment. His background in microbiology and chemistry equips him with a deep understanding of the scientific principles that underpin the innovative diagnostic solutions Roche offers.
In his current role, Ahmed leads a dynamic team focused on enhancing marketing effectiveness and aligning with the broader strategic objectives of the Marketing Excellence Chapter. His responsibilities include spearheading key projects that involve the development and execution of comprehensive marketing strategies, optimizing sales presentations, and delivering hands-on training to empower sales teams. Ahmed's leadership fosters a collaborative environment that encourages knowledge sharing and innovation, ensuring that the team remains at the forefront of market trends and customer needs.
Among his notable projects, Ahmed has successfully implemented initiatives that leverage market research to identify emerging opportunities within the diagnostics landscape, particularly in Polymerase Chain Reaction (PCR) technologies. His commitment to sales effectiveness and product management has not only driven revenue growth but also strengthened Roche's position as a leader in the molecular diagnostics field. With a keen focus on continuous improvement and excellence, Ahmed Wasfy is dedicated to advancing the capabilities of his team and delivering impactful solutions that enhance patient outcomes across the Middle East.
